Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2014 first quarter activity



(Unaudited data)




























































In thousands of euros 2013 2014 Variation at current exchange rates Variation at constant exchange rates
France 84,270 82,749 - 1.8% - 1.8%
         
International : 73,751 57,460 - 22.1% - 19.6%
Incl. Europe excluding France 54,334 39,967 - 26.4% - 24.5%
Incl. North America 15,562 12,662 - 18.6% - 14.2%
Incl. Other countries 3,855 4,831 + 25.3% + 27.9%
Group Total 158,021 140,209 - 11.3% - 10.1%








































In thousands of euros 2013 2014 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 79,062 77,919 - 1.4% - 1.1%
OTC Specialties 78,866 62,196 - 21.1% - 19.1%
Other 93 94 + 1.1% - 7.5%
Group Total 158,021 140,209 - 11.3% - 10.1%

 


HIGHLIGHTS OF THE FIRST QUARTER



  • Sales for the first quarter of 2014 is decreasing by 11.3% (-10.1% at constant exchange rate) compared to the sales for the first quarter of 2013 (in growth by 22.4% compared to 2012) which was highlighted by a high level of worldwide pathology. The lack of winter pathology substantially impacted the sales of seasonal specialties.


  • On March 31, 2014, the group's net cash position amounted 183.8 million euros versus 159.8 million euros on December 31, 2013.


  • Change in the IT department:

    After considering a restructuring plan involving around fifty employees, the General Management finally decided to cancel the plan and to study again the organization of the IT department with all the parties involved.

Given the level of activity in the first quarter and after an exceptional year 2013, the group confirms its cautiousness regarding 2014.


 


Our next updates:

May 22, 2014 at 10:30 am, at BOIRON headquarters, 2 avenue de l'Ouest Lyonnais, 69510 MESSIMY : Combined Shareholders' Meeting.

June 6, 2014: after approval by the Combined Shareholders' Meeting, payment of the proposed dividend (1.20 € per share).

July 15, 2014: after the close of the stock market, publication of the sales on June 30, 2014.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations +33 (0) 4.78.45.63.43 - e-mail: [email protected]

ISIN code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA

The group's financial information is online at:
www.boiron.com


Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Communiqué sur comptes, résultats, chiffres d'affaires

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-35606-cp-boiron_240414.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Boiron S.A. Stock

€32.65
0.620%
Boiron S.A. gained 0.620% compared to yesterday.

Like: 0
Share

Comments